Oral lactoferrin treatment of experimental oral candidiasis in mice - Wikidata - wikimedia - TriplyDB

Oral lactoferrin treatment of experimental oral candidiasis in mice

Oral lactoferrin treatment of experimental oral candidiasis in mice

http://www.wikidata.org/entity/Q24680333

about

Oral Delivery of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Liposomes and Solid Lipid Particles: Improvement of Stability of Lactoferrin.Improved RP-HPLC method for determination of bovine lactoferrin and its proteolytic degradation in simulated gastrointestinal fluids.Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasis Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin.Bovine lactoferrin: benefits and mechanism of action against infections.Reduced CX3CL1 Secretion Contributes to the Susceptibility of Oral Leukoplakia-Associated Fibroblasts to Candida albicans.Lactoferrin in human tumours: immunohistochemical investigations during more than 25 years.Apoptosis-inducing antifungal peptides and proteins.Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans.Uropathogenic Escherichia coli (UPEC) induced antimicrobial gene expression in the male reproductive tract of rat: evaluation of the potential of Defensin 21 to limit infection.Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans.Mouse salivary glands and human beta-defensin-2 as a study model for antimicrobial gene therapy: technical considerations.Use of Candida-specific chicken egg yolk antibodies to inhibit the adhering of Candida to denture base materials: prevention of denture stomatitis.Oral lactoferrin protects against experimental candidiasis in mice.Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of Candida albicans oral infection.Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms.Effects of bovine lactoferrin to oral Candida albicans and Candida glabrata isolates recovered from the saliva in elderly people.Lactoferrin: Structure, function, denaturation and digestion.Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles.Th17 cells differentiated with mycelial membranes of Candida albicans prevent oral candidiasis.Stability of bovine lactoferrin in luminal extracts and mucosal homogenates from rat intestine: a prelude to oral absorption

P2860

Q30370696-8958DD8E-797F-4728-8DAC-CE0E0AD2E601 Q34299029-FAF98985-23FA-4DEA-A9F6-826B2678BCA0 Q34416327-503C658A-F4C2-4BC6-B5F8-90EC9C7B6171 Q34429289-2DA9381B-7A01-46CD-ADCB-07938FB94DB5 Q36579322-403EB1C0-DA0B-40FF-B50F-98AAFAEEAB8B Q37408293-D417840F-3AE2-40E4-B911-45A007F00090 Q37862625-B287FB92-DE13-45F3-9030-839A7A24FDD3 Q37936568-B37F9B45-8761-4B9A-8AF9-273376B45067 Q38504324-6D3B37BB-AACF-452E-935F-C0DE803E188A Q40424835-ACAE488F-094C-4902-B402-6B047AF3614E Q41487123-725E7C9A-E2DF-41A1-ADEE-3C13288698B6 Q41498047-4AC67CC0-B277-42FB-8A21-38E631E1F352 Q41512300-3A6A8270-23EB-4AC1-A7E2-9DCCE559EFD9 Q41664368-3955812F-EB80-4572-A410-4FA5C73E13AB Q41699807-DBDD97C4-826A-4D30-AB98-F3C0D4846C25 Q42086240-FA742023-2D0F-4554-B9AA-A37EA244A6E0 Q44149226-E5CBF570-34F3-4567-A6D8-9531BB3C17C7 Q45226978-66B325F9-484D-4305-AE66-5D43B9397310 Q45344689-F842CCC3-7495-433E-A0A8-58825DC9A43D Q47652444-E58A0C23-7EE5-4E60-B34B-DE6B7DADB9B2 Q48163141-B8301B7A-1BB7-4EC5-8CF8-020D9423FEAE Q50961471-64A4A58E-3D69-452F-81F0-5BC70AD7E729 Q52692600-86B683CE-62D6-4698-B5CC-F35EB067580B Q57108578-74684781-E277-4F5F-BEEB-127052EED0E7

P2860

Oral lactoferrin treatment of experimental oral candidiasis in mice

http://www.wikidata.org/entity/Q24680333

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Oral lactoferrin treatment of experimental oral candidiasis in mice

@ast

Oral lactoferrin treatment of experimental oral candidiasis in mice

@en

Oral lactoferrin treatment of experimental oral candidiasis in mice

@nl

type

label

Oral lactoferrin treatment of experimental oral candidiasis in mice

@ast

Oral lactoferrin treatment of experimental oral candidiasis in mice

@en

Oral lactoferrin treatment of experimental oral candidiasis in mice

@nl

prefLabel

Oral lactoferrin treatment of experimental oral candidiasis in mice

@ast

Oral lactoferrin treatment of experimental oral candidiasis in mice

@en

Oral lactoferrin treatment of experimental oral candidiasis in mice

@nl

P1433

Q24680333-4B7E971A-7A86-4C2F-B6FA-C67A019B6701

P1476

Q24680333-E9FA19EE-E38D-448E-AC30-01485D94CAAD

P2093

Q24680333-31BE5865-F9C5-4E84-9D3E-C7CFD3426257

Q24680333-3B502784-5DA4-4EAD-8209-359E4E62A573

Q24680333-5D6AB091-C48E-4031-9B85-18E41E2AAD11

Q24680333-7D60A140-428B-4602-BFD2-70BCEC499D8D

Q24680333-7FCA0DDA-453B-4F3F-856D-CCF07E5040D5

Q24680333-E5B7F22E-7D84-4582-AA3F-A0FE68F8C987

Q24680333-EA47FD58-C936-45A3-AC87-20F73FA7298F

P2860

Q24680333-05253E25-2FC3-4505-BB78-7B80BBD87540

Q24680333-1B26DA5B-2528-4EF7-89B1-E46D9F94B6CE

Q24680333-30982D57-E234-43E6-8D13-6715BACEF068

Q24680333-3441DE53-B758-42BB-B166-62D0C5A59990

Q24680333-44F5368D-1888-4318-A5E7-C257E6E1D965

Q24680333-4F5B9B3B-D0BD-4F93-87D4-45789BCCE959

Q24680333-542D6E71-3C6B-4B85-85B6-20F9B20020CC

Q24680333-567C3A8C-41AA-43D5-ABFD-55905105AFBF

Q24680333-58E6D0E1-FF00-4FF3-8A6E-78CB098A8A30

Q24680333-616A1D6C-526C-4B92-AD27-644222647D11

P304

Q24680333-542ECBA9-BA37-4F35-85F5-F14212BA972D

P31

Q24680333-C2684125-E91D-41B3-9623-986EAD4864E2

P3181

Q24680333-64289827-9C93-4C12-85E7-DC2A62622D29

P356

Q24680333-3F98B60B-BED1-40AE-93ED-4644295FE1CC

P407

Q24680333-06F54178-ABCD-430A-9E4D-6090679D8D80

P433

Q24680333-75B8B59B-3D3A-424D-9D2D-D49B5983F873

P478

Q24680333-70B4459D-E1F7-478E-9BB4-2B61E7C3A44D

P577

Q24680333-6EC2FA1A-0CAF-4703-95A0-AC7A93D1829C

P698

Q24680333-0CC85340-851A-4330-85D1-D2F60BE65ACF

P932

Q24680333-E5659400-F770-4F65-A219-BC41804B16B1

P3181

P356

AAC.47.8.2619-2623.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

Oral lactoferrin treatment of experimental oral candidiasis in mice

@en

P2093

Hideyo Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Hiroko Ishibashi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Wakabayashi

http://www.w3.org/2001/XMLSchema#string

Natsuko Takakura

http://www.w3.org/2001/XMLSchema#string

Shigeru Abe

http://www.w3.org/2001/XMLSchema#string

Susumu Teraguchi

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Tamura

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the bactericidal domain of lactoferrin

Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds

Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.

Lactoferrin: a multifunctional glycoprotein.

Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models.

Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme.

Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis

Experimental oral candidiasis in animal models.

Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients

Pathogenesis, microbiological and clinical aspects of oral candidiasis (candidosis).

P304

2619-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2581856

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.47.8.2619-2623.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12878528

http://www.w3.org/2001/XMLSchema#string

P932

166093

http://www.w3.org/2001/XMLSchema#string